UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.346

Sortiert nach

Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance

Nature communications, 2021-06, Vol.12 (1), p.3528-13, Article 3528

2021

Link zum Volltext

Verfügbarkeit prüfen

Role of epidermal growth factor receptor in breast cancer

Breast cancer research and treatment, 2012-11, Vol.136 (2), p.331-345

2012

Link zum Volltext

Verfügbarkeit prüfen

Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes

Clinical cancer research, 2013-10, Vol.19 (19), p.5533-5540

2013

Link zum Volltext

Verfügbarkeit prüfen

JNK Signaling in Stem Cell Self-Renewal and Differentiation

International journal of molecular sciences, 2020-04, Vol.21 (7), p.2613

2020

Link zum Volltext

Verfügbarkeit prüfen

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

Journal of clinical oncology, 2012-02, Vol.30 (6), p.593-599

2012

Link zum Volltext

Verfügbarkeit prüfen

ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling Pathway

Molecular cancer therapeutics, 2018-12, Vol.17 (12), p.2689-2701

2018

Link zum Volltext

Verfügbarkeit prüfen

Microfluidics separation reveals the stem-cell–like deformability of tumor-initiating cells

Proceedings of the National Academy of Sciences - PNAS, 2012-11, Vol.109 (46), p.18707-18712

2012

Link zum Volltext

Verfügbarkeit prüfen

Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype

PloS one, 2019-09, Vol.14 (9), p.e0222336-e0222336

2019

Link zum Volltext

Verfügbarkeit prüfen

Targeting EGFR in Triple Negative Breast Cancer

Journal of Cancer, 2011-01, Vol.2 (1), p.324-328

2011

Link zum Volltext

Verfügbarkeit prüfen

Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer

Molecular oncology, 2015-06, Vol.9 (6), p.1155-1168

2015

Link zum Volltext

Verfügbarkeit prüfen

Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research

PloS one, 2020-04, Vol.15 (4), p.e0231953

2020

Link zum Volltext

Verfügbarkeit prüfen

Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry

Journal of clinical oncology, 2012-03, Vol.30 (7), p.729-734

2012

Link zum Volltext

Verfügbarkeit prüfen

The Emerging Impact of Social Media on Cancer Patient Education in Japan

The oncologist (Dayton, Ohio), 2018-09, Vol.23 (9), p.e105-e106

2018

Link zum Volltext

Verfügbarkeit prüfen

Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets

Clinical cancer research, 2013-09, Vol.19 (17), p.4685-4696

2013

Link zum Volltext

Verfügbarkeit prüfen

Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells

PloS one, 2015-07, Vol.10 (7), p.e0132710-e0132710

2015

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

Breast cancer research : BCR, 2011-06, Vol.13 (3), p.R67-R67, Article R67

2011

Link zum Volltext

Verfügbarkeit prüfen

EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy

PloS one, 2020, Vol.15 (3), p.e0229903-e0229903

2020

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory breast cancer: a proposed conceptual shift in the UICC–AJCC TNM staging system

The lancet oncology, 2017-04, Vol.18 (4), p.e228-e232

2017

Link zum Volltext

Verfügbarkeit prüfen

MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model

Molecular cancer therapeutics, 2015-12, Vol.14 (12), p.2773-2781

2015

Link zum Volltext

Verfügbarkeit prüfen

Update on systemic treatment for newly diagnosed inflammatory breast cancer

Journal of advanced research, 2021-03, Vol.29, p.1-12

2021

Link zum Volltext

Verfügbarkeit prüfen

CYP2D6 Genotype-Guided Tamoxifen Dosing in Hormone Receptor-Positive Metastatic Breast Cancer (TARGET-1): A Randomized, Open-Label, Phase II Study

Journal of clinical oncology, 2020-02, Vol.38 (6), p.558-566

2020

Link zum Volltext

Verfügbarkeit prüfen

Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer

Clinical cancer research, 2017-08, Vol.23 (16), p.4780-4792

2017

Link zum Volltext

Verfügbarkeit prüfen

Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review

PloS one, 2021-04, Vol.16 (4), p.e0250057-e0250057

2021

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models

Oncotarget, 2016-12, Vol.7 (50), p.82482-82492

2016

Link zum Volltext

Verfügbarkeit prüfen

Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors

Oncoimmunology, 2021-01, Vol.10 (1), p.1929724-1929724

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.346

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.160)
Mit Volltextzugriff
(1.266)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.302)
Japanisch
(344)
Koreanisch
(3)
Deutsch
(2)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(127)
Journal Of Clinical Oncology
(80)
Breast Cancer Research And Treatment
(29)
Journal Of Cancer
(27)
Plos One
(27)
Biochemical And Biophysical Research Communications
(25)
Developmental Biology
(23)
Molecular Cancer Therapeutics
(23)
Blood
(22)
Cancer
(22)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance

Role of epidermal growth factor receptor in breast cancer

Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes

JNK Signaling in Stem Cell Self-Renewal and Differentiation

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK-AKT-mTOR Signaling Pathway

Microfluidics separation reveals the stem-cell–like deformability of tumor-initiating cells

Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype

Targeting EGFR in Triple Negative Breast Cancer

Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer

Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research

Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry

The Emerging Impact of Social Media on Cancer Patient Education in Japan

Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets

Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy

Inflammatory breast cancer: a proposed conceptual shift in the UICC–AJCC TNM staging system

MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model

Update on systemic treatment for newly diagnosed inflammatory breast cancer

CYP2D6 Genotype-Guided Tamoxifen Dosing in Hormone Receptor-Positive Metastatic Breast Cancer (TARGET-1): A Randomized, Open-Label, Phase II Study

Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer

Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review

Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models

Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors

Suchergebnisse filtern